After the company submitted safety, immunogenicity and efficacy data, the Subject Expert Committee granted permission for conducting the trials in India.
from NDTV News - Topstories https://ift.tt/3znnT9D
Wednesday, September 15, 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment